(Q39141673)
Statements
Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276 (English)
J Schmidt
E Braggio
K M Kortuem
J B Egan
Y X Zhu
C S Xin
S E Palmer
V M Garbitt
D McCauley
M Kauffman
S Shacham
M Chesi
P L Bergsagel